William F Doyle - Net Worth and Insider Trading
William F Doyle Net Worth
The estimated net worth of William F Doyle is at least $9 Million dollars as of 2024-05-06. William F Doyle is the Executive Chairman of NovoCure Ltd and owns about 551,176 shares of NovoCure Ltd (NVCR) stock worth over $8 Million. William F Doyle is the Director of Elanco Animal Health Inc and owns about 61,330 shares of Elanco Animal Health Inc (ELAN) stock worth over $829,795. William F Doyle is also the Director of Minerva Neurosciences Inc and owns about 3,264 shares of Minerva Neurosciences Inc (NERV) stock worth over $7,736. Details can be seen in William F Doyle's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that William F Doyle has not made any transactions after 2024-03-08 and currently still holds the listed stock(s).
Transaction Summary of William F Doyle
William F Doyle Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, William F Doyle owns 7 companies in total, including NovoCure Ltd (NVCR) , Minerva Neurosciences Inc (NERV) , and OptiNose Inc (OPTN) among others .
Click here to see the complete history of William F Doyle’s form 4 insider trades.
Insider Ownership Summary of William F Doyle
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
NVCR | NovoCure Ltd | 2022-08-02 | director & 10 percent owner |
NERV | Minerva Neurosciences Inc | 2019-06-27 | director |
OPTN | OptiNose Inc | 2017-10-12 | director & 10 percent owner |
2015-02-03 | director | ||
2024-03-08 | director | ||
2022-07-11 | director | ||
2022-07-11 | director |
William F Doyle Latest Holdings Summary
William F Doyle currently owns a total of 3 stocks. Among these stocks, William F Doyle owns 551,176 shares of NovoCure Ltd (NVCR) as of August 2, 2022, with a value of $8 Million and a weighting of 90.68%. William F Doyle owns 61,330 shares of Elanco Animal Health Inc (ELAN) as of March 8, 2024, with a value of $829,795 and a weighting of 9.24%. William F Doyle also owns 3,264 shares of Minerva Neurosciences Inc (NERV) as of June 27, 2019, with a value of $7,736 and a weighting of 0.09%.
Latest Holdings of William F Doyle
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
NVCR | NovoCure Ltd | 2022-08-02 | 551,176 | 14.78 | 8,146,381 |
ELAN | Elanco Animal Health Inc | 2024-03-08 | 61,330 | 13.53 | 829,795 |
NERV | Minerva Neurosciences Inc | 2019-06-27 | 3,264 | 2.37 | 7,736 |
Holding Weightings of William F Doyle
William F Doyle Form 4 Trading Tracker
According to the SEC Form 4 filings, William F Doyle has made a total of 19 transactions in NovoCure Ltd (NVCR) over the past 5 years, including 0 buys and 19 sells. The most-recent trade in NovoCure Ltd is the sale of 837 shares on August 2, 2022, which brought William F Doyle around $58,305.
According to the SEC Form 4 filings, William F Doyle has made a total of 1 transactions in Elanco Animal Health Inc (ELAN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Elanco Animal Health Inc is the acquisition of 15,000 shares on March 8, 2024, which cost William F Doyle around $244,500.
According to the SEC Form 4 filings, William F Doyle has made a total of 1 transactions in Minerva Neurosciences Inc (NERV) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Minerva Neurosciences Inc is the acquisition of 438 shares on June 27, 2019, which cost William F Doyle around $19,250.
Insider Trading History of William F Doyle
- 1
William F Doyle Trading Performance
GuruFocus tracks the stock performance after each of William F Doyle's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William F Doyle is -2.84%. GuruFocus also compares William F Doyle's trading performance to market benchmark return within the same time period. The performance of stocks bought by William F Doyle within 3 months outperforms 2 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how William F Doyle's insider trading performs compared to the benchmark.
Performance of William F Doyle
William F Doyle Ownership Network
Ownership Network List of William F Doyle
Ownership Network Relation of William F Doyle
William F Doyle Owned Company Details
What does NovoCure Ltd do?
Who are the key executives at NovoCure Ltd?
William F Doyle is the director & 10 percent owner of NovoCure Ltd. Other key executives at NovoCure Ltd include Chief Financial Officer Wilhelmus Cm Groenhuysen , President & CNS Cancers US Frank X Leonard , and Chief Commercial Officer Pritesh Shah .
NovoCure Ltd (NVCR) Insider Trades Summary
Over the past 18 months, William F Doyle made no insider transaction in NovoCure Ltd (NVCR). Other recent insider transactions involving NovoCure Ltd (NVCR) include a net sale of 62,300 shares made by Frank X Leonard , a net sale of 25,323 shares made by Pritesh Shah , and a net sale of 32,769 shares made by Wilhelmus Cm Groenhuysen .
In summary, during the past 3 months, insiders sold 10,224 shares of NovoCure Ltd (NVCR) in total and bought 0 shares, with a net sale of 10,224 shares. During the past 18 months, 352,694 shares of NovoCure Ltd (NVCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 352,694 shares.
NovoCure Ltd (NVCR)'s detailed insider trading history can be found in Insider Trading Tracker table.
NovoCure Ltd Insider Transactions
William F Doyle Mailing Address
Above is the net worth, insider trading, and ownership report for William F Doyle. Currently GuruFocus does not have mailing address information for William F Doyle.